Orgenesis (ORGS) News Today → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free ORGS Stock Alerts $0.47 -0.05 (-9.62%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31, 2024 | investorplace.comORGS Stock Earnings: Orgenesis Reported Results for Q4 2023May 21, 2024 | investorplace.comORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024May 21, 2024 | globenewswire.comOrgenesis Provides Business Update for the First Quarter of 2024April 17, 2024 | investing.comOrgenesis secures $2.3 million investment and strategic partnershipApril 17, 2024 | finanznachrichten.deOrgenesis Inc.: Orgenesis Provides Year End Business UpdateApril 15, 2024 | globenewswire.comOrgenesis Provides Year End Business UpdateApril 11, 2024 | investing.comGermfree partners with Orgenesis to enhance CGT productionApril 10, 2024 | globenewswire.comGermfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global AccessibilityMarch 18, 2024 | globenewswire.comVered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe ConferenceMarch 13, 2024 | globenewswire.comOrgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic ExosomesMarch 4, 2024 | globenewswire.comOrgenesis Inc. Announces $2.3 Million Private PlacementFebruary 29, 2024 | globenewswire.comOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP ManufacturingFebruary 23, 2024 | finance.yahoo.comOrgenesis Inc. (ORGS)February 22, 2024 | morningstar.comOrgenesis Inc ORGSJanuary 31, 2024 | msn.comEXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To ClinicJanuary 31, 2024 | finance.yahoo.comOrgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to ClinicJanuary 8, 2024 | finance.yahoo.comOrgenesis Inc. (ORGS) Stock Historical Prices & Data - Yahoo FinanceNovember 22, 2023 | finance.yahoo.comAnalysts Expect Orgenesis Inc. (NASDAQ:ORGS) To Breakeven SoonNovember 15, 2023 | finanznachrichten.deOrgenesis Inc.: Orgenesis Provides Business Update for the Third Quarter of 2023November 14, 2023 | finance.yahoo.comOrgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TMNovember 13, 2023 | finance.yahoo.comOrgenesis Provides Business Update for the Third Quarter of 2023November 8, 2023 | finance.yahoo.comOrgenesis Inc. Announces Pricing of $1.1 Million Registered Direct OfferingNovember 5, 2023 | forbes.com6 Secrets Of Organizations That Successfully Adapt To ChangeNovember 2, 2023 | finance.yahoo.comOrgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant FundingOctober 31, 2023 | finanznachrichten.deOrgenesis Inc.: Orgenesis Announces Withdrawal of Proposed Public OfferingOctober 30, 2023 | finance.yahoo.comOrgenesis Announces Withdrawal of Proposed Public OfferingOctober 30, 2023 | finance.yahoo.comOrgenesis Announces Proposed Underwritten Public OfferingSeptember 21, 2023 | stockhouse.comCGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United StatesSeptember 21, 2023 | finance.yahoo.comCGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United StatesAugust 28, 2023 | finance.yahoo.comOrgenesis Inc (ORGS): A Deep Dive into Its Performance PotentialAugust 28, 2023 | finance.yahoo.comIs Orgenesis (ORGS) Too Good to Be True? A Comprehensive Analysis of a Potential Value TrapAugust 24, 2023 | finance.yahoo.comOrgenesis (ORGS): A Value Trap in Disguise?August 13, 2023 | abcnews.go.comHow to help Maui fire victims from afar: Organizations and efforts underwayAugust 11, 2023 | finanznachrichten.deOrgenesis Inc.: Orgenesis Provides Business Update for Second Quarter of 2023August 11, 2023 | finance.yahoo.comOrgenesis Provides Business Update for Second Quarter of 2023August 10, 2023 | finance.yahoo.comOrgenesis Schedules Second Quarter 2023 Business Update Conference CallJuly 13, 2023 | finanznachrichten.deOrgenesis Inc.: Orgenesis Appoints Finance Veteran Elliot Maltz as its Chief Financial OfficerJuly 13, 2023 | marketwatch.comOrgenesis Names Maltz Finance Chief as Reithinger Resigns >ORGSJuly 13, 2023 | finance.yahoo.comOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief Financial OfficerJuly 11, 2023 | finance.yahoo.comOrgenesis Announces Name Change of Morgenesis Business Unit to OctomeraJune 15, 2023 | finance.yahoo.comOrgenesis Inc. (NASDAQ:ORGS) On The Verge Of Breaking EvenJune 7, 2023 | finance.yahoo.comOrgenesis and University of California, Davis Sign Partnership Agreement for Rollout of Cell and Gene Therapy Mobile Processing Units and Labs Throughout CaliforniaMay 30, 2023 | finance.yahoo.comClaudia Zylberberg Appointed as Independent Board Member of POCare Business Subsidiary of OrgenesisMay 22, 2023 | benzinga.comOrgenesis Academy Graduates First Class of Cell and Gene Therapy Experts from theraCell Laboratories-backed Master's ProgramMay 22, 2023 | finance.yahoo.comOrgenesis Academy Graduates First Class of Cell and Gene Therapy Experts from theraCell Laboratories-backed Master’s ProgramMay 19, 2023 | finance.yahoo.comOrgenesis to Participate in Benchmark’s 3rd Annual Healthcare House Call Virtual 1x1 Investor Conference on May 23, 2023May 18, 2023 | finance.yahoo.comOrgenesis Announces Collaboration Agreement with SCTbio to Expand POCare Sites in the Czech Republic and Enhance Capabilities for the Production of Lentivirus VectorsMay 10, 2023 | finance.yahoo.comOrgenesis Provides Business Update for the First Quarter of 2023 and Reports Continued Progress on its POCare StrategyMay 10, 2023 | finance.yahoo.comOrgenesis Secures an Additional $5 Million Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Service SubsidiaryApril 26, 2023 | forbes.comThe Secret To Sustainability For Non-profit Organizations Get Orgenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s Final Masterpiece: “X-9840” (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. ORGS Media Mentions By Week ORGS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORGS News Sentiment▼0.000.73▲Average Medical News Sentiment ORGS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORGS Articles This Week▼00▲ORGS Articles Average Week Get Orgenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Immix Biopharma News Theratechnologies News CalciMedica News Leap Therapeutics News Reneo Pharmaceuticals News BioLineRx News Carisma Therapeutics News Rockwell Medical News AEON Biopharma News Anebulo Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORGS) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored25% of Americans Are In Grave DangerAccording to this White House briefing … AI will replace up to 300 million jobs. That would amount to 25% of A...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored